Symbols / IRTC
IRTC Chart
About
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with BioIS to develop and commercialize pulse oximetry, accelerometry, and trending non-invasive blood pressure technologies for use within our ambulatory cardiac monitoring products and services. The company was formerly known as iRhythm Technologies, Inc. and changed its name to iRhythm Holdings, Inc. in January 2026. iRhythm Holdings, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 4.42B |
| Enterprise Value | 4.58B | Income | -44.55M | Sales | 747.14M |
| Book/sh | 4.73 | Cash/sh | 18.06 | Dividend Yield | — |
| Payout | 0.00% | Employees | 2400 | IPO | — |
| P/E | — | Forward P/E | 163.93 | PEG | — |
| P/S | 5.91 | P/B | 28.99 | P/C | — |
| EV/EBITDA | -149.77 | EV/Sales | 6.13 | Quick Ratio | 4.34 |
| Current Ratio | 4.63 | Debt/Eq | 478.69 | LT Debt/Eq | — |
| EPS (ttm) | -1.62 | EPS next Y | 0.84 | EPS Growth | — |
| Revenue Growth | 27.10% | Earnings | 2026-04-30 | ROA | -2.36% |
| ROE | -36.57% | ROIC | — | Gross Margin | 70.57% |
| Oper. Margin | 4.20% | Profit Margin | -5.96% | Shs Outstand | 32.22M |
| Shs Float | 32.00M | Short Float | 9.84% | Short Ratio | 4.18 |
| Short Interest | — | 52W High | 212.00 | 52W Low | 92.52 |
| Beta | 1.07 | Avg Volume | 595.52K | Volume | 663.15K |
| Target Price | $212.87 | Recom | Strong_buy | Prev Close | $141.22 |
| Price | $137.10 | Change | -2.92% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$212.87
Mean price target
2. Current target
$137.10
Latest analyst target
3. DCF / Fair value
$40.04
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$137.10
Low
$184.00
High
$254.00
Mean
$212.87
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-23 | reit | Truist Securities | Buy → Buy | $200 |
| 2026-02-20 | main | Canaccord Genuity | Buy → Buy | $198 |
| 2026-02-20 | main | JP Morgan | Overweight → Overweight | $215 |
| 2026-02-20 | main | Wells Fargo | Overweight → Overweight | $200 |
| 2026-02-20 | main | Baird | Outperform → Outperform | $200 |
| 2026-01-13 | main | Wells Fargo | Overweight → Overweight | $225 |
| 2026-01-12 | reit | Needham | Buy → Buy | $244 |
| 2026-01-05 | up | Evercore ISI Group | In-Line → Outperform | $210 |
| 2025-12-18 | main | Truist Securities | Buy → Buy | $215 |
| 2025-12-16 | main | Baird | Outperform → Outperform | $220 |
| 2025-12-02 | main | Morgan Stanley | Overweight → Overweight | $205 |
| 2025-10-31 | main | Canaccord Genuity | Buy → Buy | $212 |
| 2025-10-31 | main | Citigroup | Buy → Buy | $242 |
| 2025-10-31 | main | JP Morgan | Overweight → Overweight | $240 |
| 2025-10-31 | main | Baird | Outperform → Outperform | $235 |
| 2025-10-31 | main | Goldman Sachs | Neutral → Neutral | $202 |
| 2025-10-31 | main | Needham | Buy → Buy | $244 |
| 2025-10-31 | main | BTIG | Buy → Buy | $215 |
| 2025-10-15 | main | Truist Securities | Buy → Buy | $205 |
| 2025-10-13 | main | BTIG | Buy → Buy | $195 |
- iRhythm Holdings, Inc. (IRTC) Stock Analysis: Exploring a 41% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews Mon, 23 Feb 2026 20
- How iRhythm’s Profit Return and 2026 Outlook Could Reshape the Story for iRhythm Holdings (IRTC) Investors - simplywall.st ue, 24 Feb 2026 19
- Analysts Are Bullish on Top Healthcare Stocks: Abivax SA Sponsored ADR (ABVX), Irhythm Technologies (IRTC) - The Globe and Mail ue, 24 Feb 2026 20
- IRTC: Truist Securities Reiterates Buy Rating, Lowers Price Targ - GuruFocus Mon, 23 Feb 2026 15
- Why iRhythm (IRTC) Stock Is Trading Up Today - Yahoo Finance Fri, 31 Oct 2025 07
- Here’s Artisan Mid Cap Fund’s Updates on iRhythm (IRTC) - Insider Monkey ue, 24 Feb 2026 12
- $IRTC stock is down 9% today. Here's what we see in our data. - Quiver Quantitative ue, 13 Jan 2026 08
- iRhythm, agilon health, GoodRx, Fortrea, and Myriad Genetics Stocks Trade Down, What You Need To Know - Finviz Mon, 23 Feb 2026 17
- iRhythm Holdings, Inc. (IRTC) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance hu, 19 Feb 2026 22
- IRTC Analyst Update: JP Morgan Lowers Price Target for iRhythm H - GuruFocus Fri, 20 Feb 2026 20
- Wells Fargo Keeps Their Buy Rating on Irhythm Technologies (IRTC) - The Globe and Mail Sat, 21 Feb 2026 08
- IRTC: Canaccord Genuity Lowers Price Target Despite Retaining Bu - GuruFocus Fri, 20 Feb 2026 21
- Why iRhythm (IRTC) Stock Is Up Today - Yahoo Finance Mon, 22 Dec 2025 08
- A Look At iRhythm Holdings (IRTC) Valuation After Record Revenue And First Quarterly Profit - simplywall.st Mon, 23 Feb 2026 08
- Wells Fargo Maintains iRhythm Holdings (IRTC) Rating, Lowers Pri - GuruFocus Fri, 20 Feb 2026 19
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 2478 | 458009 | — | Sale at price 184.83 per share. | MURPHY PATRICK MICHAEL | Officer | — | 2025-12-02 00:00:00 | D |
| 1 | 280 | 51752 | — | Sale at price 184.83 per share. | PATTERSON CHAD | Officer | — | 2025-12-02 00:00:00 | D |
| 2 | 73 | 13725 | — | Stock Award(Grant) at price 188.01 per share. | SHRISHRIMAL SUMI | Officer | — | 2025-11-28 00:00:00 | D |
| 3 | 250 | 47002 | — | Stock Award(Grant) at price 188.01 per share. | TURAKHIA MINANG | Officer | — | 2025-11-28 00:00:00 | D |
| 4 | 2 | 376 | — | Stock Award(Grant) at price 188.01 per share. | ROSENBAUM MARK W | Officer | — | 2025-11-28 00:00:00 | D |
| 5 | 5312 | 924962 | — | Sale at price 172.32 - 177.85 per share. | TALWALKAR ABHIJIT Y | Director | — | 2025-11-10 00:00:00 | D |
| 6 | 5312 | 56892 | — | Conversion of Exercise of derivative security at price 10.71 per share. | TALWALKAR ABHIJIT Y | Director | — | 2025-11-10 00:00:00 | D |
| 7 | 14059 | 2571907 | — | Sale at price 182.94 per share. | BLACKFORD QUENTIN S | Chief Executive Officer | — | 2025-11-03 00:00:00 | D |
| 8 | 8000 | 1659520 | — | Sale at price 207.44 per share. | WILSON DANIEL G | Chief Financial Officer | — | 2025-10-31 00:00:00 | D |
| 9 | 5000 | 875000 | — | Sale at price 175.00 per share. | WILSON DANIEL G | Chief Financial Officer | — | 2025-09-03 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -1.73M | -2.33M | -5.59M | 0.00 |
| TaxRateForCalcs | 0.21 | 0.21 | 0.21 | 0.27 |
| NormalizedEBITDA | -65.90M | -85.78M | -65.53M | -83.23M |
| TotalUnusualItems | -8.23M | -11.08M | -26.61M | 0.00 |
| TotalUnusualItemsExcludingGoodwill | -8.23M | -11.08M | -26.61M | 0.00 |
| NetIncomeFromContinuingOperationNetMinorityInterest | -113.29M | -123.41M | -116.16M | -101.36M |
| ReconciledDepreciation | 25.78M | 22.14M | 19.61M | 16.59M |
| ReconciledCostOfRevenue | 184.31M | 160.88M | 129.29M | 109.26M |
| EBITDA | -74.13M | -96.86M | -92.14M | -83.23M |
| EBIT | -99.90M | -119.01M | -111.75M | -99.83M |
| NetInterestIncome | 9.12M | 2.70M | -1.79M | -1.05M |
| InterestExpense | 12.82M | 3.65M | 4.14M | 1.17M |
| InterestIncome | 21.94M | 6.35M | 2.35M | 118.00K |
| NormalizedIncome | -106.79M | -114.65M | -95.13M | -101.36M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -113.29M | -123.41M | -116.16M | -101.36M |
| TotalExpenses | 706.70M | 606.76M | 498.10M | 422.77M |
| TotalOperatingIncomeAsReported | -115.50M | -125.16M | -113.78M | -99.94M |
| DilutedAverageShares | 31.20M | 30.53M | 29.92M | 29.33M |
| BasicAverageShares | 31.20M | 30.53M | 29.92M | 29.33M |
| DilutedEPS | -3.63 | -4.04 | -3.88 | -3.46 |
| BasicEPS | -3.63 | -4.04 | -3.88 | -3.46 |
| DilutedNIAvailtoComStockholders | -113.29M | -123.41M | -116.16M | -101.36M |
| NetIncomeCommonStockholders | -113.29M | -123.41M | -116.16M | -101.36M |
| NetIncome | -113.29M | -123.41M | -116.16M | -101.36M |
| NetIncomeIncludingNoncontrollingInterests | -113.29M | -123.41M | -116.16M | -101.36M |
| NetIncomeContinuousOperations | -113.29M | -123.41M | -116.16M | -101.36M |
| TaxProvision | 565.00K | 750.00K | 269.00K | 367.00K |
| PretaxIncome | -112.72M | -122.66M | -115.89M | -100.99M |
| OtherIncomeExpense | -6.98M | -11.28M | -26.92M | 118.00K |
| OtherNonOperatingIncomeExpenses | 1.25M | -198.00K | -314.00K | 118.00K |
| SpecialIncomeCharges | -8.23M | -11.08M | -26.61M | 0.00 |
| OtherSpecialCharges | 7.59M | |||
| WriteOff | 641.00K | 0.00 | 0.00 | |
| ImpairmentOfCapitalAssets | 0.00 | 11.08M | 23.16M | 0.00 |
| RestructuringAndMergernAcquisition | 0.00 | 0.00 | 3.44M | 0.00 |
| NetNonOperatingInterestIncomeExpense | 9.12M | 2.70M | -1.79M | -1.05M |
| InterestExpenseNonOperating | 12.82M | 3.65M | 4.14M | 1.17M |
| InterestIncomeNonOperating | 21.94M | 6.35M | 2.35M | 118.00K |
| OperatingIncome | -114.86M | -114.08M | -87.18M | -99.94M |
| OperatingExpense | 522.39M | 445.89M | 368.81M | 313.51M |
| ResearchAndDevelopment | 103.83M | 60.24M | 46.61M | 38.67M |
| SellingGeneralAndAdministration | 418.56M | 385.64M | 322.20M | 274.84M |
| GrossProfit | 407.53M | 331.81M | 281.63M | 213.57M |
| CostOfRevenue | 184.31M | 160.88M | 129.29M | 109.26M |
| TotalRevenue | 591.84M | 492.68M | 410.92M | 322.82M |
| OperatingRevenue | 591.84M | 492.68M | 410.92M | 322.82M |
| Line Item | 2024-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 229.00K | |||
| OrdinarySharesNumber | 31.39M | 30.95M | 30.19M | 29.49M |
| ShareIssued | 31.62M | 30.95M | 30.19M | 29.49M |
| NetDebt | 226.85M | |||
| TotalDebt | 736.91M | 129.82M | 131.04M | 117.71M |
| TangibleBookValue | 90.05M | 209.24M | 238.95M | 278.65M |
| InvestedCapital | 737.35M | 245.05M | 274.75M | 300.87M |
| WorkingCapital | 534.90M | 123.44M | 199.68M | 217.67M |
| NetTangibleAssets | 90.05M | 209.24M | 238.95M | 278.65M |
| CapitalLeaseObligations | 90.47M | 94.87M | 96.10M | 96.35M |
| CommonStockEquity | 90.91M | 210.10M | 239.81M | 279.51M |
| TotalCapitalization | 737.35M | 245.05M | 274.75M | 289.20M |
| TotalEquityGrossMinorityInterest | 90.91M | 210.10M | 239.81M | 279.51M |
| StockholdersEquity | 90.91M | 210.10M | 239.81M | 279.51M |
| GainsLossesNotAffectingRetainedEarnings | 165.00K | -112.00K | -396.00K | -61.00K |
| OtherEquityAdjustments | 165.00K | -112.00K | -396.00K | -61.00K |
| TreasuryStock | 25.00M | 0.00 | ||
| RetainedEarnings | -758.89M | -645.61M | -522.20M | -406.05M |
| AdditionalPaidInCapital | 874.61M | 855.78M | 762.38M | 685.59M |
| CapitalStock | 31.00K | 31.00K | 28.00K | 27.00K |
| CommonStock | 31.00K | 31.00K | 28.00K | 27.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 840.54M | 223.05M | 208.41M | 183.45M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 729.62M | 115.68M | 119.31M | 95.60M |
| OtherNonCurrentLiabilities | 8.58M | 1.01M | 1.31M | 697.00K |
| LongTermDebtAndCapitalLeaseObligation | 721.04M | 114.67M | 118.01M | 94.90M |
| LongTermCapitalLeaseObligation | 74.60M | 79.72M | 83.07M | 85.21M |
| LongTermDebt | 646.44M | 34.95M | 34.94M | 9.69M |
| CurrentLiabilities | 110.92M | 107.37M | 89.10M | 87.85M |
| CurrentDeferredLiabilities | 2.93M | 3.31M | 3.05M | 3.05M |
| CurrentDeferredRevenue | 2.93M | 3.31M | 3.05M | 3.05M |
| CurrentDebtAndCapitalLeaseObligation | 15.87M | 15.16M | 13.03M | 22.81M |
| CurrentCapitalLeaseObligation | 15.87M | 15.16M | 13.03M | 11.14M |
| CurrentDebt | 11.67M | |||
| OtherCurrentBorrowings | 11.67M | |||
| PensionandOtherPostRetirementBenefitPlansCurrent | 585.00K | 1.04M | 1.04M | 1.00M |
| PayablesAndAccruedExpenses | 91.54M | 87.87M | 71.97M | 60.99M |
| CurrentAccruedExpenses | 78.30M | 74.87M | 57.60M | 47.50M |
| InterestPayable | 78.00K | |||
| Payables | 13.24M | 13.00M | 14.37M | 13.50M |
| OtherPayable | 2.01M | 4.58M | 4.46M | 2.99M |
| TotalTaxPayable | 4.01M | 2.88M | 2.39M | |
| AccountsPayable | 7.22M | 5.54M | 7.52M | 10.51M |
| TotalAssets | 931.45M | 433.14M | 448.22M | 462.97M |
| TotalNonCurrentAssets | 285.63M | 202.33M | 159.45M | 157.44M |
| OtherNonCurrentAssets | 50.21M | 45.04M | 22.25M | 16.05M |
| InvestmentsAndAdvances | 61.90M | 3.00M | ||
| InvestmentinFinancialAssets | 61.90M | 3.00M | ||
| GoodwillAndOtherIntangibleAssets | 862.00K | 862.00K | 862.00K | 862.00K |
| Goodwill | 862.00K | 862.00K | 862.00K | 862.00K |
| NetPPE | 172.66M | 153.43M | 136.34M | 140.53M |
| AccumulatedDepreciation | -71.22M | -50.50M | -35.22M | -22.70M |
| GrossPPE | 243.88M | 203.93M | 171.55M | 163.24M |
| Leases | 27.12M | 24.89M | 23.14M | 20.40M |
| ConstructionInProgress | 71.44M | 53.82M | 31.52M | 17.69M |
| OtherProperties | 57.25M | 55.32M | 65.58M | 87.78M |
| MachineryFurnitureEquipment | 88.07M | 69.91M | 51.31M | 37.37M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 645.82M | 230.81M | 288.77M | 305.52M |
| OtherCurrentAssets | 16.29M | 21.59M | 10.55M | 9.69M |
| PrepaidAssets | 10.55M | 9.69M | ||
| Inventory | 14.04M | 13.97M | 15.15M | 10.27M |
| FinishedGoods | 8.18M | 7.67M | 5.82M | 5.17M |
| RawMaterials | 5.86M | 6.30M | 9.34M | 5.10M |
| Receivables | 79.94M | 61.48M | 49.92M | 46.43M |
| AccountsReceivable | 79.94M | 61.48M | 49.92M | 46.43M |
| AllowanceForDoubtfulAccountsReceivable | -16.25M | -20.29M | -18.48M | -14.01M |
| GrossAccountsReceivable | 96.19M | 81.77M | 68.39M | 60.44M |
| CashCashEquivalentsAndShortTermInvestments | 535.55M | 133.76M | 213.14M | 239.13M |
| OtherShortTermInvestments | 115.96M | 97.59M | 134.31M | 111.57M |
| CashAndCashEquivalents | 419.60M | 36.17M | 78.83M | 127.56M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -45.55M | -90.53M | -52.84M | -65.82M |
| RepurchaseOfCapitalStock | -25.00M | 0.00 | 0.00 | |
| RepaymentOfDebt | -116.41M | 0.00 | -21.47M | -11.67M |
| IssuanceOfDebt | 736.25M | 0.00 | 35.00M | 0.00 |
| IssuanceOfCapitalStock | 0.00 | 0.00 | ||
| CapitalExpenditure | -48.94M | -40.42M | -29.83M | -28.07M |
| InterestPaidSupplementalData | 6.39M | 2.96M | 3.32M | 1.19M |
| IncomeTaxPaidSupplementalData | 923.00K | 1.13M | 287.00K | 0.00 |
| EndCashPosition | 427.95M | 36.17M | 78.83M | 127.56M |
| BeginningCashPosition | 36.17M | 78.83M | 127.56M | 88.63M |
| EffectOfExchangeRateChanges | -6.00K | -169.00K | 0.00 | 0.00 |
| ChangesInCash | 391.79M | -42.49M | -48.73M | 38.93M |
| FinancingCashFlow | 511.38M | 8.82M | 26.72M | -28.58M |
| CashFlowFromContinuingFinancingActivities | 511.38M | 8.82M | 26.72M | -28.58M |
| NetOtherFinancingCharges | -91.93M | -77.00K | -25.85M | |
| ProceedsFromStockOptionExercised | 8.47M | 8.82M | 13.18M | 8.94M |
| NetCommonStockIssuance | -25.00M | 0.00 | 0.00 | 0.00 |
| CommonStockPayments | -25.00M | 0.00 | 0.00 | |
| CommonStockIssuance | 0.00 | 0.00 | ||
| NetIssuancePaymentsOfDebt | 619.84M | 0.00 | 13.53M | -11.67M |
| NetLongTermDebtIssuance | 619.84M | 0.00 | 13.53M | -11.67M |
| LongTermDebtPayments | -116.41M | 0.00 | -21.47M | -11.67M |
| LongTermDebtIssuance | 736.25M | 0.00 | 35.00M | 0.00 |
| InvestingCashFlow | -122.98M | -1.21M | -52.43M | 105.26M |
| CashFlowFromContinuingInvestingActivities | -122.98M | -1.21M | -52.43M | 105.26M |
| NetInvestmentPurchaseAndSale | -74.04M | 39.22M | -22.60M | 133.33M |
| SaleOfInvestment | 101.20M | 206.50M | 165.97M | 255.51M |
| PurchaseOfInvestment | -175.24M | -167.28M | -188.57M | -122.18M |
| NetIntangiblesPurchaseAndSale | -15.00M | 0.00 | 0.00 | |
| PurchaseOfIntangibles | -15.00M | 0.00 | 0.00 | |
| NetPPEPurchaseAndSale | -33.94M | -40.42M | -29.83M | -28.07M |
| PurchaseOfPPE | -33.94M | -40.42M | -29.83M | -28.07M |
| OperatingCashFlow | 3.39M | -50.10M | -23.01M | -37.75M |
| CashFlowFromContinuingOperatingActivities | 3.39M | -50.10M | -23.01M | -37.75M |
| ChangeInWorkingCapital | -99.12M | -102.05M | -65.51M | -46.23M |
| ChangeInOtherWorkingCapital | -374.00K | 255.00K | 2.00K | 2.12M |
| ChangeInOtherCurrentLiabilities | -7.72M | -5.59M | -2.98M | 264.00K |
| ChangeInOtherCurrentAssets | 3.22M | -22.79M | -6.20M | -1.83M |
| ChangeInPayablesAndAccruedExpense | -7.41M | 17.32M | 11.48M | 14.08M |
| ChangeInAccruedExpense | 19.30M | 14.47M | 7.95M | |
| ChangeInPayable | -1.97M | -2.99M | 6.13M | |
| ChangeInAccountPayable | -1.97M | -2.99M | 6.13M | |
| ChangeInPrepaidAssets | 5.30M | -11.04M | -862.00K | -2.33M |
| ChangeInInventory | -224.00K | 979.00K | -5.11M | -4.96M |
| ChangeInReceivables | -91.92M | -81.19M | -61.84M | -53.57M |
| ChangesInAccountReceivables | -91.92M | -81.19M | -61.84M | -53.57M |
| OtherNonCashItems | 35.60M | 337.00K | 264.00K | 6.75M |
| StockBasedCompensation | 75.98M | 77.20M | 57.74M | 54.53M |
| UnrealizedGainLossOnInvestmentSecurities | -1.90M | 0.00 | 0.00 | |
| ProvisionandWriteOffofAssets | 73.46M | 69.63M | 58.35M | 37.07M |
| AssetImpairmentCharge | 641.00K | 11.08M | 23.16M | 0.00 |
| AmortizationOfSecurities | -1.35M | -5.04M | -474.00K | 1.64M |
| DepreciationAmortizationDepletion | 25.78M | 22.14M | 19.61M | 16.59M |
| DepreciationAndAmortization | 25.78M | 22.14M | 19.61M | 16.59M |
| Depreciation | 25.78M | 22.14M | 19.61M | 16.59M |
| OperatingGainsLosses | 7.59M | |||
| NetIncomeFromContinuingOperations | -113.29M | -123.41M | -116.16M | -101.36M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for IRTC
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|